BACKGROUND: we aimed to characterize the financial needs expressed through online crowdfunding for urologic cancers. METHODS: the data used in this study came from the online crowdfunding platform GoFundMe.com. Using an automated software method, we extracted data for campaigns related to urologic cancers. Subsequently, four independent investigators reviewed all extracted data on prostate, bladder, kidney and testicular cancer. We analyzed campaigns' basic characteristics, goals, fundraising, type of treatment and factors associated with successful campaigns. RESULTS: in total, we identified 2126 individual campaigns, which were related to direct treatment costs (34%), living expenses (17%) or both (48%). Median fundraising amounts were greatest for testicular cancer. Campaigns for both complementary and alternative medicine (CAM) (median $11,000) or CAM alone (median $8527) achieved higher fundraising totals compared with those for conventional treatments alone (median $5362) (p < 0.01). The number of social media shares was independently associated with campaign success and highest quartile of fundraising. CONCLUSIONS: using an automated web-based approach, we identified and characterized online crowdfunding for urologic cancer care. These findings indicated a diverse range of patient needs related to urologic care and factors related to campaigns' success.

Data Science and Clinical Analytics New Century Health Boston MA 02481 USA

Department of Biostatistics and Epidemiology University of California San Francisco San Francisco CA 94143 USA

Department of Minimally Invasive and Robotic Urology University Center of Excellence in Urology Wroclaw Medical University 50 556 Wroclaw Poland

Department of Urology 2nd Faculty of Medicine Charles University 15006 Prague Czech Republic

Department of Urology La Croix du Sud Hospital 31130 Quint Fonsegrives France

Department of Urology Medical University of Silesia 41 800 Zabrze Poland

Department of Urology Medical University of Vienna 1090 Vienna Austria

Department of Urology University of California San Francisco San Francisco CA 94143 USA

Department of Urology University of Texas Southwestern Dallas TX 75390 USA

Department of Urology Weill Cornell Medical College New York NY 10021 USA

Department of Urology Yale University School of Medicine New Haven CT 06520 USA

Division of Oncology Unit of Urology Urological Research Institute IRCCS Ospedale San Raffaele 20132 Milan Italy

Hourani Center for Applied Scientific Research Al Ahliyya Amman University Amman 19328 Jordan

Institute for Urology and Reproductive Health Sechenov University 119435 Moscow Russia

Karl Landsteiner Institute of Urology and Andrology 1090 Vienna Austria

000      

00000naa a2200000 a 4500

001      

bmc22023443

003      

CZ-PrNML

005      

20221031095204.0

007      

ta

008      

221010s2022 sz f 000 0|eng||

009      

AR

024    7_

$a 10.3390/cancers14174104 $2 doi

035    __

$a (PubMed)36077641

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a sz

100    1_

$a Rajwa, Pawel $u Department of Urology, Medical University of Vienna, 1090 Vienna, Austria $u Department of Urology, Medical University of Silesia, 41-800 Zabrze, Poland

245    10

$a Online Crowdfunding for Urologic Cancer Care / $c P. Rajwa, P. Hopen, J. Wojnarowicz, J. Kaletka, I. Paszkiewicz, O. Lach-Wojnarowicz, H. Mostafaei, W. Krajewski, D. D'Andrea, B. Małkiewicz, A. Paradysz, G. Ploussard, M. Moschini, BN. Breyer, B. Pradere, SF. Shariat, MS. Leapman

520    9_

$a BACKGROUND: we aimed to characterize the financial needs expressed through online crowdfunding for urologic cancers. METHODS: the data used in this study came from the online crowdfunding platform GoFundMe.com. Using an automated software method, we extracted data for campaigns related to urologic cancers. Subsequently, four independent investigators reviewed all extracted data on prostate, bladder, kidney and testicular cancer. We analyzed campaigns' basic characteristics, goals, fundraising, type of treatment and factors associated with successful campaigns. RESULTS: in total, we identified 2126 individual campaigns, which were related to direct treatment costs (34%), living expenses (17%) or both (48%). Median fundraising amounts were greatest for testicular cancer. Campaigns for both complementary and alternative medicine (CAM) (median $11,000) or CAM alone (median $8527) achieved higher fundraising totals compared with those for conventional treatments alone (median $5362) (p &lt; 0.01). The number of social media shares was independently associated with campaign success and highest quartile of fundraising. CONCLUSIONS: using an automated web-based approach, we identified and characterized online crowdfunding for urologic cancer care. These findings indicated a diverse range of patient needs related to urologic care and factors related to campaigns' success.

655    _2

$a časopisecké články $7 D016428

700    1_

$a Hopen, Philip $u Data Science & Clinical Analytics, New Century Health, Boston, MA 02481, USA

700    1_

$a Wojnarowicz, Jakub $u Department of Urology, Medical University of Silesia, 41-800 Zabrze, Poland

700    1_

$a Kaletka, Julia $u Department of Urology, Medical University of Silesia, 41-800 Zabrze, Poland

700    1_

$a Paszkiewicz, Iga $u Department of Urology, Medical University of Silesia, 41-800 Zabrze, Poland $1 0000000202067044

700    1_

$a Lach-Wojnarowicz, Olga $u Department of Urology, Medical University of Silesia, 41-800 Zabrze, Poland

700    1_

$a Mostafaei, Hadi $u Department of Urology, Medical University of Vienna, 1090 Vienna, Austria

700    1_

$a Krajewski, Wojciech $u Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, 50-556 Wroclaw, Poland

700    1_

$a D'Andrea, David $u Department of Urology, Medical University of Vienna, 1090 Vienna, Austria $1 0000000316251077

700    1_

$a Małkiewicz, Bartosz $u Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, 50-556 Wroclaw, Poland $1 0000000259333753

700    1_

$a Paradysz, Andrzej $u Department of Urology, Medical University of Silesia, 41-800 Zabrze, Poland

700    1_

$a Ploussard, Guillaume $u Department of Urology, La Croix du Sud Hospital, 31130 Quint Fonsegrives, France

700    1_

$a Moschini, Marco $u Division of Oncology, Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, 20132 Milan, Italy

700    1_

$a Breyer, Benjamin N $u Department of Urology, University of California San Francisco, San Francisco, CA 94143, USA $u Department of Biostatistics and Epidemiology, University of California San Francisco, San Francisco, CA 94143, USA

700    1_

$a Pradere, Benjamin $u Department of Urology, Medical University of Vienna, 1090 Vienna, Austria $u Department of Urology, La Croix du Sud Hospital, 31130 Quint Fonsegrives, France $1 0000000277688558

700    1_

$a Shariat, Shahrokh F $u Department of Urology, Medical University of Vienna, 1090 Vienna, Austria $u Institute for Urology and Reproductive Health, Sechenov University, 119435 Moscow, Russia $u Karl Landsteiner Institute of Urology and Andrology, 1090 Vienna, Austria $u Department of Urology, Weill Cornell Medical College, New York, NY 10021, USA $u Department of Urology, University of Texas Southwestern, Dallas, TX 75390, USA $u Department of Urology, Second Faculty of Medicine, Charles University, 15006 Prague, Czech Republic $u Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman 19328, Jordan

700    1_

$a Leapman, Michael S $u Department of Urology, Yale University School of Medicine, New Haven, CT 06520, USA

773    0_

$w MED00173178 $t Cancers $x 2072-6694 $g Roč. 14, č. 17 (2022)

856    41

$u https://pubmed.ncbi.nlm.nih.gov/36077641 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y - $z 0

990    __

$a 20221010 $b ABA008

991    __

$a 20221031095202 $b ABA008

999    __

$a ind $b bmc $g 1853869 $s 1174731

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2022 $b 14 $c 17 $e 20220825 $i 2072-6694 $m Cancers $n Cancers (Basel) $x MED00173178

LZP    __

$a Pubmed-20221010